BridgeBio Oncology Therapeutics (BBOT) targets KRAS and PI3Ka malignancies with next-generation small molecule therapeutics, ...
The loss of domvanalimab is the latest in a string of high-profile failures recorded across the biopharma world for the TIGIT ...
Two leading medical stocks that appear reasonable at current levels are AbbVie (NYSE: ABBV) and Merck (NYSE: MRK). The former ...
Researchers led by investigators at Mass General Brigham have published valuable information about a rare but serious complication of anti-cancer immunotherapy, providing the first large-scale ...
MERCK SERONO S.A. v. HOPEWELL PHARMA VENTURES, INC. - Before Hughes, Linn, and Cunningham. Appeal from the Patent Trial and Appeal Board.
Preoperative radiation improved T-cell infiltration among patients with hormone receptor-positive, HER2-negative breast ...
Merck Animal Health announced that the Food and Drug Administration granted conditional approval for EXOLT CATTLE-CA 1. It’s a new topical that’s approved for the prevention and treatment of ...
Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...
Federal officials say the U.S. Food and Drug Administration (FDA) is reviewing reports of possible deaths in adults and ...
Firms with significant exposure to federal spending, government contracts and regulatory approvals are now tallying up the ...
Merck Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA, on Dec. 4 announced the Food and Drug Administration ...
Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results